Ultrastructure of enterochromaffin cells and associated neural and vascular elements in the mouse duodenum
Key results: 15 mg dose: Average weight loss of 22.5 percent (approximately 52 pounds for a 230-pound individual) 10 mg dose: Average weight loss of 21.4 percent 5 mg dose: Average weight loss of 16.0 percent Over 85 percent of participants at 10 mg or 15 mg lost at least 10 percent of body weight Over 50 percent at 15 mg lost at least 20 percent SURMOUNT-5, a head-to-head trial comparing tirzepatide to semaglutide, confirmed tirzepatides superiority at matched doses
they also leave sticky residue for days that wont come off no matter how hard you scrub
Common CPT Codes Office Visits (2021 E/M Guidelines) 9920299205 New patient visits 9921199215 Established patient visits Obesity Counseling 9940199404 Preventive counseling (commercial payers) G0447 Face-to-face obesity counseling (Medicare) Diabetes Self-Management Training G0108 Individual DSMT G0109 Group DSMT Prior Authorization & Payer Policy Requirements Most payers require prior authorization (PA) for GLP-1 medications
GLP-1based injections are administered weekly at our clinic
GLP-1 agonism does three main things: slows gastric emptying (food stays in your stomach longer, so you feel full), reduces appetite signaling in the brain, and stimulates insulin release in response to food
